What is the etiopathogenesis of hidradenitis suppurativa in a young adult female with a history of acne and obesity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Etiopathogenesis of Hidradenitis Suppurativa

Hidradenitis suppurativa is primarily a disease of follicular occlusion, beginning with infundibulofolliculitis and follicular hyperkeratosis, followed by follicular rupture that triggers a robust inflammatory cascade involving both innate and adaptive immunity. 1

Primary Pathogenic Event: Follicular Occlusion

The initiating event in HS is follicular hyperkeratosis and occlusion of the hair follicle infundibulum, not primary apocrine gland pathology as historically believed 1. Histopathological studies demonstrate:

  • Follicular hyperplasia and hyperkeratosis with spongiform infundibulofolliculitis as the earliest detectable change 1
  • Follicular dilatation and rupture releasing keratin and follicular contents into the dermis 1
  • Secondary involvement of apocrine glands occurs after the initial follicular event 2
  • Formation of keratin-containing cysts, abscesses, sinus tracts, granulomas, and eventual fibrosis 1

This follicular occlusion mechanism explains why the term "acne inversa" may be more pathogenetically accurate 2.

Genetic Susceptibility

Up to 42% of patients report a family history, with autosomal dominant inheritance patterns observed in some kindreds 1. Key genetic findings include:

  • Heterozygous mutations in γ-secretase genes (NCSTN, PSEN1, PSENEN) underlie familial cases 1
  • These γ-secretase alterations in animal models directly result in follicular occlusion, linking genetic defects to the primary pathogenic mechanism 1
  • Higher β-defensin copy numbers have been associated with HS in small cohorts 1
  • Single nucleotide polymorphisms in TNF and IL-12RB1 genes have been identified, though genetic testing has no current clinical role 1

Immune Dysregulation

The disease involves hyperactivation of both innate and adaptive immunity, with the innate system predominating in early disease and adaptive responses amplifying chronic inflammation 3:

Innate Immunity

  • Elevated pro-inflammatory cytokines including TNF-α, IL-1β, IL-6, and IL-17A 1
  • Macrophage activation within visceral adipose tissue contributes to systemic cytokine elevation 1
  • Biofilm formation in sinus tracts may perpetuate inflammation, though bacteria appear to be secondary colonizers rather than primary causative agents 1, 4

Adaptive Immunity

  • T-cell predominance in the lymphocytic infiltrate of early lesions 2
  • High percentage of HLA-DR positive lymphocytes with inverse relationship to Leu-8 positive cells 2
  • Sharp decline in T-helper/suppressor ratio after disease initiation 2
  • The significant response to anti-TNF agents (particularly adalimumab) supports aberrant immunity as a key pathogenic driver 1

Hormonal Influences

Female predominance (3:1 ratio), post-pubertal onset, premenstrual flares, and pregnancy-related changes strongly implicate hormonal factors, though exact mechanisms remain unclear 1, 5, 6:

  • Disease typically manifests between ages 20-30 years, after puberty 5
  • Clinical improvement often observed during pregnancy 1
  • Exacerbations correlate with menstrual cycles in many women 6
  • Three-fold increased risk of polycystic ovarian syndrome (up to 9% prevalence) 1
  • Androgen influences are suggested by response to antiandrogen therapies in some patients 1

Extrinsic Contributing Factors

Smoking

Approximately 70-75% of patients with HS are active smokers 1:

  • Nicotine induces epidermal hyperplasia and follicular plugging 1
  • Association with disease severity, duration, and treatment failure in some studies 1
  • Smoking cessation has resulted in complete remission in documented cases 1

Obesity

Prevalence of overweight/obesity exceeds 75% in HS patients 1:

  • Obesity increases mechanical friction at flexural sites, potentially damaging follicular outlets 1
  • Increases sweat retention in intertriginous areas 1
  • Visceral adipose tissue secretes pro-inflammatory cytokines (IL-1β, TNF-α) systemically 1
  • Odds ratio of 33 for HS compared to controls 5
  • Weight loss >15% has been associated with disease improvement or remission in case series 1

Microbiome Alterations

  • Mixed normal flora and skin commensals are cultured from suppurative discharge, with gram-negative organisms abundant in some lesions 1, 4
  • Biofilms present in most HS skin samples, especially sinus tracts, though their pathogenic role versus secondary colonization remains unclear 1, 4
  • Short courses of antibiotics do not alter flare natural history, suggesting bacterial involvement is secondary 1
  • Antibiotic benefits likely derive from anti-inflammatory rather than antimicrobial properties 1

Clinical Context for Young Adult Female with Acne and Obesity

In this specific patient population, the pathogenesis involves convergence of multiple risk factors:

  • Follicular occlusion tendency shared with acne vulgaris (part of follicular occlusion tetrad) 1, 5
  • Hormonal influences from post-pubertal androgen activity and potential PCOS 1, 6
  • Obesity-mediated mechanical stress and pro-inflammatory cytokine elevation 1, 5
  • Increased friction in intertriginous areas from body habitus 1
  • Potential genetic predisposition requiring family history assessment 1

The combination of these factors creates a perfect storm: follicular occlusion initiates the process, obesity amplifies mechanical and inflammatory contributions, and hormonal fluctuations trigger flares, all occurring in a patient with likely genetic susceptibility to follicular disorders 1, 5, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bacterial Profile in Hidradenitis Suppurativa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Demographic Profile and Clinical Characteristics of Hidradenitis Suppurativa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hidradenitis suppurativa pathogenesis: Extrinsic factors.

Journal of the American Academy of Dermatology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.